Dendritic cells (DCs) perform a basic role in the immune system by allowing the initiation of the primary T-cell-dependent immune response. Given previous indirect evidence that DC maturation and function are impaired by HIV, we have developed an in vitro culture system in order to verify the effect of HIV infection on DC function during the development from hematopoietic progenitors. Considering that monocytic (Mo) differentiating cells efficiently replicate monocytotropic HIV, we examined whether HI V-infected monocytic precursors (MoP) were able to generate functional DCs. CD34+ hematopoietic progenitor cells (HPCs) were induced along Mo differentiative pathway in liquid cultures and at an early stage of culture, MoP were infected with M-tropic HaL HIV strain, and after 2 days they were switched to DC differentiation with GM-CSF and IL-4. Derived DCs were actively infected, as detected by HIV-p24 production. HIV did not significantly affect cell viability, but induced a reduction in cell proliferation and an inefficient functional activity in terms of uptake capability and stimulation of allogenic T cells. These results indicate that HIV-infected MoP lost the capacity to generate functional DCs, and this may represent one of the many mechanisms of immunosuppression exploited by HIV.
Dendritic cells (DCs) perform a basic role in the immune system by allowing the initiation of the primary T-cell-dependent immune response. Given previous indirect evidence that DC maturation and function are impaired by HIV, we have developed an in vitro culture system in order to verify the effect of HIV infection on DC function during the development from hematopoietic progenitors. Considering that monocytic (Mo) differentiating cells efficiently replicate monocytotropic HIV, we examined whether HI V-infected monocytic precursors (MoP) were able to generate functional DCs. CD34+ hematopoietic progenitor cells (HPCs) were induced along Mo differentiative pathway in liquid cultures and at an early stage of culture, MoP were infected with M-tropic HaL HIV strain, and after 2 days they were switched to DC differentiation with GM-CSF and IL-4. Derived DCs were actively infected, as detected by HIV-p24 production. HIV did not significantly affect cell viability, but induced a reduction in cell proliferation and an inefficient functional activity in terms of uptake capability and stimulation of allogenic T cells. These results indicate that HIV-infected MoP lost the capacity to generate functional DCs, and this may represent one of the many mechanisms of immunosuppression exploited by HIV.
Dendritic cells (DCs) are the most effective stimulators of primary T-cell responses, and may thus represent a strategic target for evasion of immune control by the pathogens. Many viruses have developed mechanisms to evade the immune system response (l, 2) also by interfering with the maturation and function of DCs (3) (4) (5) .
DCs develop from bone marrow-derived hematopoietic stem cells, and their precursors migrate via the blood stream to peripheral tissue where they become professional antigen presenting cells (APCs) (6) . DC population comprises multiple cell subsets that are effective in antigen processing and presentation (7, 8) .
Although their role in HIV immunopathogenesis has been largely studied, conclusive data on DC functionality in patients infected with HIV are still not available. Several studies have demonstrated that HIV impairs DC function in terms of CD4 T-cell activation (9) (10) (11) (12) , IFN-a production (13, 14) and IL-12 secretion (15, 16) . On the other hand, Sabado et al. reported that DCs from HIV primary infected patients can react or overreact to stimuli and elicit T-cell activation (17) . Moreover, whether, to which extent, or at which maturative stage DCs are infected by HIV remains highly controversial (18) (19) (20) (21) (22) . Conversely, the effect of HlV on differentiation and function of DCs derived from in vitro infected precursors appears irrelevant (23, 24) or the effect depends on the stage of maturation of the DC when exposure to virus occurs (25) .
By using an in vitro culture model, it has previously been shown that early MoP derived from CD34+ hematopoietic progenitors can generate functional DCs. These studies strongly indicate that DCs may directly derive from immature Mo precursors other than peripheral blood (PB) mature monocytes (26) . Based on these data, and considering that Mo differentiating cells efficiently replicate monocytotropic HIV (27, 28) , we examined whether HlV-infected Mo precursors were able to generate functional DCs.
MATERIALS AND METHODS

Lymphocyte isolation and CD34 purification.
Peripheral blood mononuclear cells (PBMCs) from healthy donors were isolated by Lympholyte (Cedarlane, Canada). Hematopoietic progenitor cells (HPCs) were purified from PBMCs by immunomagnetic separation using anti-CD34-conjugated magnetic microbeads (Miltenyi Biotec, Germany). The percentage of CD34+ cells was >95% in all experiments, as measured by flow cytometry analysis (data not shown).
Monocytic uni/ineage HPC liquid suspension culture.
HPCs were seeded at 2 x 10 5 cells/ml and induced to Mo differentiation in IMDM supplemented with 20% heat inactivated fetal calfserum (FCS), 2 mmol/L L-glutamine, 100 mg /mL penicillin, and 100 mg/ml, streptomycin (Gibco, Carlsbad, CA, USA), Flt3 ligand (100 ng/mL), Monocyte-Colony Stimulating Factor (M-CSF) (500 U) and IL-6 I ng/mL (Peprotech, Rocky Hill, NJ, USA) (32) . The cells, cultivated in a fully humidified atmosphere (5% CO, 5% 0 and 90% N,) were periodically counted and 2 2 _ analyzed through the 16 days of culture.
Generation ofDCs
At day 8 of culture, monocytic precursors were either HIV-I-BaL or mock infected, washed and seeded in fresh Mo differentiation medium. After 2 days from infection, cells were cultured for an additional 5 days (or for more time for p24 detection) in RPMI 1640 supplemented with 10% FCS with L-glutamine and antibiotics, in the presence of 50 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF) and 10 ng/mL IL-4 (Peprotech, Rocky Hill, NJ, USA). The resulting DCs were treated with I mg/mL Lipopolysaccharide (LPS) (Sigma-Aldrich, Steinheim, Germany) for 16 h in order to induce maturation.
HIV-l-BaL infection and p24 detection
HIV-BaL virus preparations were obtained as described (29) and titrated as picograms per milliliter of p24 protein by ELISA assay (Abbott, North Chicago, IL, USA). HIV infection of purified CD34+ cells was performed on 2.5x10 5 cells by adsorbing 75 ng ofHIV-Bal for 2 h at 37°C, and then washing infected cells in order to exclude any virus carry-over; infection was controlled by measuring p24 protein by ELISA assay. In order to exclude possible interference by soluble factors released by infected CEM cells, ultracentrifuged supernatants were used in a preliminary test. The comparison between this test and those obtained with non-ultracentrifuged supernatants showed that the influence of soluble factors were negligible. The culture supernatants were periodically harvested for p24 release determination monitored by ELISA assay (Abbott).
Fl'FCsdextran uptake assay
Either infected or mock-infected DCs were incubated at 37°C for 30 min with I mg/rnl, FITC-dextran (Sigma-Aldrich). To assess the background uptake, identical samples were incubated 30 min at 4°C. Cells were then washed twice with PBS/O.I% BSA and analyzed by flow cytometry.
Mixed leukocyte reaction
Responder allogenic adult T lymphocytes (10 5 cells per well in 96-well U-bottomed culture plates; Costar or Falcon) were cultured for 6 days with graded numbers of MoP or DC in 100 mL of IMDM containing 10% FCS L-glutamine and antibiotics as described above. Incorporation of 3H-thymidine (I mCi per well, ICN Biomedicals, Irvine, CA) was assessed by 18-hour pulse; the cells were harvested using a 96-well cell harvester (Tomtec, Hamden, CT) and the thymidine incorporation was measured in a Microbeta counter (Wallac, Turku, Finland).
Statistical analysis
Statistical significance was determined by GraphPad Prism software (GraphPad). Differences between groups were evaluated by non-parametric Mann-Whitney test. Tests were considered significant when p < 0.05.
RESULTS
HIV infects monocytic precursors and productively replicates in the derived DCs
The combined treatment of hematopoietic progenitor cells (HPCs) with M-CSF, IL-6 and Flt3 ligand resulted in HPC proliferation and selective Mo differentiation/maturation (26) ; replacement of the Mo specific culture medium with GM-CSF and IL-4 resulted in the generation of DCs, as depicted in Fig.  1 . After 8 days of unilineage culture, proliferating MoP were tested for their susceptibility to HIV infection by the monocyte-tropic strain BaL; after an additional 2 days, MoP were extensively washed and switched to DCs by culturing them in GM-CSF and IL-4 containing medium, as indicated in Fig. 1 . In order to verify the productive infection, HIV-p24 levels were measured in supernatants from DCs derived from infected MoP at different time after infection. As shown in Fig. 2 , p24 level increased at day 5 reaching 25 ng/mL at day 7 pos-infection, indicating HIV infection and replication in DCs. Interestingly, intracytoplasmic staining ofgag-related proteins on LPS-stimulated DCs showed that only 15% of the total cells were HIV positive and that the DC phenotype was not significantly affected in the presence ofHIV (% CDla+ cells: mock median 55% (lQR 37-64), HIV-BaL 63% (46-74) not significant (n.s.); % CD86+ cells: mock 54% (28-80), HIV-BaL 45% (21-77) (n.s.); % CDI4+ cells: mock 48% (43-82), HIV-BaL 35% (31-73) (n.s.).
HIV infection reduces DC proliferation
To verify whether HIV infection with M-tropic strain affects the expansion capability ofDCs derived from MoP, proliferative rate and cell viability were evaluated. MoP were induced into DCs 2 days after infection when the proliferative rate of both infected and not infected cells was similar. We found that DCs derived from HIV-I-BaL infected MoP (at 1, 2, 5 and 7 days post-infection) were not able to proliferate (Fig. 3) . Moreover, infected derived DCs demonstrated a low but not significant increase of the percentage of Annexin positive cells in respect to mock DCs (% Annexin+ cells: mock median 6% (IQR 5-6.5), HIV-BaL 8% (5-12) (n.s.).
DCs from HIV-infected Mo precursors are impaired in their functions
DCs uninfected Mo precursors were analyzed for their endocytic capability by measuring FITC-conjugated dextran uptake. About 37% of uninfected DCs were able to endocytose, whereas a marked reduction was observed in BaL infected Des (Fig. 4 panel A) .
Since we observed a down modulation of costimulatory molecules and phagocytic capacity, we tested whether HIV infection can also impair their antigen presentation ability. To this aim, we cultured DCs derived from HIV-I-BaL-infected or mockinfected Mo precursors with allogenic T lymphocytes and T-cell proliferation was analyzed in a mixed leukocyte reaction test. As shown in Fig. 4 panel B , DCs obtained from mock infected Mo precursors were able to stimulate allogenic T-cell proliferation. In contrast, significant reduction in T-cell proliferation was observed when DCs derived from BaL-infected MoP were used as APCs, suggesting that mv specifically interferes with DC functions.
DISCUSSION
The impairment of DC homeostasis during HIV infection is central to both the spread of the infection and the progression of the immunodeficiency.
We previously described a culture model which allows CD34+ HPC proliferation and differentiation toward monocytic lineage, and upon treatment with GM-CSF and IL-4, further switching to functional DCs (26) . In the present work, we used this model to verify whether the challenge ofmonocytic precursors (MoP) with HIV could affect the generation of functional DCs.
We showed that challenged MoP actively replicated the mono-cytotropic BaL strain early after infection. Therefore, this method may be a useful tool to evaluate how HIV infection may affect the expansion and differentiation of hematopoietic precursors.
DCs from HIV+ patients show increased apoptosis compared with DCs from uninfected individuals (30, 31) . However, it is not clear whether HIV infection could inhibit the expansion of DC precursors. In the present work we show that HIV is able to reduce the growth rate of derived DCs, but the reduction did not correlate with a significant cell death, suggesting that mechanisms other than apoptosis are involved.
The degree of inhibition of DC proliferation by HIV paralleled the inability of the infected DCs to exert their main functions. The defective allogenic antigen-presentation, as well as the reduced endocytic capability, were evident in HIV-infected DCs. Although there is an overall consensus that blood DC numbers decline during HIV infection, it is unclear whether DCs from patients or in vitroinfected DCs are functionally impaired. It has been proposed that functional defects of DCs isolated from infected individuals, such as their inability to activate allogenic T cells are probably due to a defective maturation process (i.e., a deficient costimulatory and adhesion molecule expression) (32, 33) . On the contrary, it has been reported that during primary HIV infection, DCs retain the ability to stimulate T-cell response and respond to stimuli despite their reduction in number (32, 33) . These discordant findings may result from the different experimental systems used to analyze DCs, and from different stages of HIV disease.
In our study the relevant effects of HIV infection on CD34+-derived MoP cannot be fully explained by a virus-driven damage, due to the low fraction of infected cells. Other mechanisms probably mediated by soluble factors released by infected cells could explain the relevant effect on bystander uninfected cells, as for example the release ofNefprotein, known to interfere with monocyte precursors differentiation (34) . However, this issue needs further investigation.
The biology of DCs is considered central in the pathogenesis of HIV infection due to its role in effective adaptive immunity induction. Depletion and dysfunction of DCs observed in HIV+ patients have thus been proposed to playa role in pathogenesis of HIV infection. Direct infection of DCs has been suggested to be responsible for decreased DC frequency during HIV infection (9) . Given the low level of HIV+-infected DCs, it is unlikely that direct infection may adequately explain the decreased DC frequency in the blood of HIV-infected patients. Instead, the decline of DC frequency during viral infection may be due to indirect mechanisms. It has been reported that aberrant IFN-a production during HIV infection may impede the differentiation ofDCs from monocytes (35) or other precursors.
In conclusion, our findings support the hypothesis that the infection on DC precursors is one of the causes of DC function impairment observed in HIV patients.
Further studies are needed to determine how CD34+ hematopoietic precursor differentiation into DCs may be affected in vivo during different stages of HIV disease, in particular during the primary infection, when probably most damage takes place.
